Olivier Pamlard

445 total citations
15 papers, 351 citations indexed

About

Olivier Pamlard is a scholar working on Molecular Biology, Oncology and Infectious Diseases. According to data from OpenAlex, Olivier Pamlard has authored 15 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Infectious Diseases. Recurrent topics in Olivier Pamlard's work include Drug Transport and Resistance Mechanisms (4 papers), Plant-Microbe Interactions and Immunity (3 papers) and Epigenetics and DNA Methylation (2 papers). Olivier Pamlard is often cited by papers focused on Drug Transport and Resistance Mechanisms (4 papers), Plant-Microbe Interactions and Immunity (3 papers) and Epigenetics and DNA Methylation (2 papers). Olivier Pamlard collaborates with scholars based in France, Malaysia and Switzerland. Olivier Pamlard's co-authors include Eric Jacquet, Jean‐Yves Lallemand, Christina Sizun, Catherine Guillou, Nicolas Leulliot, Nathalie Ulryck, Jérôme Bignon, Hélène Levaïque, Joëlle Dubois and Camille Decroocq and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Molecular Biology and Biochemical Journal.

In The Last Decade

Olivier Pamlard

15 papers receiving 344 citations

Peers

Countries citing papers authored by Olivier Pamlard

Since Specialization

Citations

This map shows the geographic impact of Olivier Pamlard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olivier Pamlard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olivier Pamlard more than expected).

Fields of papers citing papers by Olivier Pamlard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olivier Pamlard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olivier Pamlard. The network helps show where Olivier Pamlard may publish in the future.

Co-authorship network of co-authors of Olivier Pamlard

This figure shows the co-authorship network connecting the top 25 collaborators of Olivier Pamlard. A scholar is included among the top collaborators of Olivier Pamlard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olivier Pamlard. Olivier Pamlard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Alkyl-Resorcinol Derivatives as Inhibitors of GDP-Mannose Pyrophosphorylase with Antileishmanial Activities 2021 ·Molecules ·Hélène Levaïque, Olivier Pamlard, Cécile Apel, Jérôme Bignon, (unknown), (unknown), Khalijah Awang, Philippe M. Loiseau, Marc Litaudon, Sébastien Pomel	5
2	Identification of two compounds able to improve flax resistance towards Fusarium oxysporum infection 2020 ·Plant Science ·(unknown), (unknown), Elodie Mathieu‐Rivet, Marie‐Christine Kiefer‐Meyer, (unknown), Carole Plasson, Olivier Pamlard, (unknown), (unknown), Catherine Guillou, Azeddine Driouich, Marie‐Laure Follet‐Gueye, Jean‐Claude Mollet	5
3	Inhibition of p53-Murine Double Minute 2 (MDM2) Interactions with 3,3′-Spirocyclopentene Oxindole Derivatives 2018 ·Journal of Medicinal Chemistry ·Maxime Gicquel, Catherine Gomez, (unknown), Olivier Pamlard, Vincent Guérineau, Eric Jacquet, Jérôme Bignon, Arnaud Voituriez, Angéla Marinetti	30
4	Design and Synthesis of Tubulin and Histone Deacetylase Inhibitor Based on iso-Combretastatin A-4 2018 ·Journal of Medicinal Chemistry ·(unknown), (unknown), Léna Zig, (unknown), Guillaume Bollot, Jérôme Bignon, Hélène Levaïque, Olivier Pamlard, Joëlle Dubois, Mehdi Ouaïssi, Martin Soucé, Athéna Kasselouri, François Saller, Delphine Borgel, Chantal Jayat‐Vignoles, (unknown), Jean Feuillard, Karim Benihoud, Mouâd Alami, Abdallah Hamzé	66
5	Holaphyllamine, a steroid, is able to induce defense responses in Arabidopsis thaliana and increases resistance against bacterial infection 2017 ·Planta ·(unknown), (unknown), (unknown), Arnaud Lehner, Isabelle Rémy‐Jouet, Olivier Pamlard, (unknown), Jérôme Leprince, Marie‐Laure Follet‐Gueye, Mäite Vicré‐Gibouin, Xavier Latour, Vincent Richard, Catherine Guillou, Patrice Lerouge, Azeddine Driouich, Jean‐Claude Mollet	8
6	A direct label-free MALDI-TOF mass spectrometry based assay for the characterization of inhibitors of protein lysine methyltransferases 2017 ·Analytical and Bioanalytical Chemistry ·(unknown), (unknown), Fabienne Burlina, Sandrine Sagan, (unknown), Olivier Pamlard, (unknown), Catherine Guillou, Gérard Bolbach, Emmanuelle Sachon, Dominique Guianvarc’h	16
7	Iminosugars as a new class of cholinesterase inhibitors 2014 ·Bioorganic & Medicinal Chemistry Letters ·Camille Decroocq, (unknown), Olivier Pamlard, (unknown), Estelle Gallienne, Olivier R. Martin, Catherine Guillou, Philippe Compain	30
8	A Rapid in Vivo Colorimetric Library Screen for Inhibitors of Microbial Respiration 2012 ·ACS Chemical Biology ·Cindy Vallières, Nicholas Fisher, Marc D. Lemoine, Olivier Pamlard, (unknown), Catherine Guillou, Brigitte Meunier	3
9	A Phenotypic Assay to Identify Chikungunya Virus Inhibitors Targeting the Nonstructural Protein nsP2 2012 ·SLAS DISCOVERY ·Marianne Lucas‐Hourani, Alexandru Lupan, Philippe Desprès, Sylviane Thoret, Olivier Pamlard, Joëlle Dubois, Catherine Guillou, Frédéric Tangy, Pierre‐Olivier Vidalain, Hélène Munier‐Lehmann	30
10	Evaluation of natural products as potential cosmetic agents with tyrosinase inhibition activity 2012 ·Planta Medica ·(unknown), Eliza Chaita, Nektarios Aligiannis, (unknown), Eleftherios Kalpoutzakis, Aikaterini Termentzi, (unknown), Matthias Hamburger, Vincent Dumontet, Olivier Pamlard, Françoise Guéritte, AL Skaltsounis	3
11	ATP Hydrolysis and Pristinamycin IIA Inhibition of the Staphylococcus aureus Vga(A), a Dual ABC Protein Involved in Streptogramin A Resistance 2008 ·Journal of Biological Chemistry ·Eric Jacquet, Jean‐Marie Girard, (unknown), Olivier Pamlard, Hélène Levaïque, Jean‐Michel Betton, Elie Dassa, O. Chesneau	28
12	Structure of the Human Multidrug Resistance Protein 1 Nucleotide Binding Domain 1 bound to Mg2+/ATP Reveals a Non-productive Catalytic Site 2006 ·Journal of Molecular Biology ·(unknown), Nicolas Leulliot, Christina Sizun, Nathalie Ulryck, Olivier Pamlard, Jean‐Yves Lallemand, (unknown), Eric Jacquet	67
13	Attempts to characterize the NBD heterodimer of MRP1: transient complex formation involves Gly771 of the ABC signature sequence but does not enhance the intrinsic ATPase activity 2005 ·Biochemical Journal ·(unknown), Christina Sizun, Olivier Pamlard, Eric Jacquet, Jean‐Yves Lallemand	26
14	Biochemical characterization and NMR studies of the nucleotide-binding domain 1 of multidrug-resistance-associated protein 1: evidence for interaction between ATP and Trp653 2003 ·Biochemical Journal ·(unknown), (unknown), Francis Duffieux, Olivier Pamlard, Marine Oberkampf, Jean‐Yves Lallemand, Véronique Stoven, Eric Jacquet	16
15	Nucleotide‐binding domain 1 of cystic fibrosis transmembrane conductance regulator 2000 ·European Journal of Biochemistry ·Francis Duffieux, Jean‐Philippe Annereau, Julien Boucher, Emeric Miclet, Olivier Pamlard, Michael Schneider, Véronique Stoven, Jean‐Yves Lallemand	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact